π Parabilis Medicines
Parabilis Medicines is a biopharmaceutical organization engaged in drug development and clinical research activities that are monitored within global intelligence frameworks for regulatory compliance and international market development.
3
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| After raising $800M, Parabilis seeks an IPO to pursue βundruggableβ targets | active | AI & Tech | investor | 100% | |
| STAT+: Pioneering trial for treating genetic disease before birth nears reality | active | Health | involved | 100% | |
| Justice Department agrees not to pursue any tax claims against Trump as part of IRS deal | expired | Deals | involved | 100% |